HEALTHY PARTICIPANTS
Clinical trials for HEALTHY PARTICIPANTS explained in plain language.
Never miss a new study
Get alerted when new HEALTHY PARTICIPANTS trials appear
Sign up with your email to follow new studies for HEALTHY PARTICIPANTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat vaccine aims to shield seniors from three winter viruses
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests a new vaccine called VXB-251 in 240 healthy adults aged 60-83. The vaccine is designed to protect against three viruses that can cause serious lung infections: RSV, hMPV, and PIV3. Researchers will check if the vaccine is safe and how well it triggers…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 03, 2026 12:02 UTC
-
Herbal pills and walking: a new weight loss combo?
Disease control OngoingThis study tests whether two herbal supplements (CL19183 and CL24212) can help overweight adults lose weight and improve metabolic health. About 150 healthy but overweight participants (BMI 25-30) will take the supplements or a placebo, follow a standard diet, and walk 30 minutes…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: ApexCPG LLC • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New Cholesterol-Lowering pill tested in healthy volunteers
Disease control OngoingThis early-stage study tests a new drug called AZD0780 in 40 healthy adults with high LDL (bad) cholesterol. Participants receive either the drug or a placebo to see if it safely lowers cholesterol levels. The goal is to gather initial safety and effectiveness data before moving …
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 27, 2026 11:49 UTC
-
Yearly flu shot alternative? new drug tested for Long-Term safety
Prevention OngoingThis study tests the safety of giving repeated annual doses of an experimental drug called CD388 to healthy adults. About 400 people who already tolerated one dose without serious side effects will receive two more doses over two years. Researchers will monitor for side effects a…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE2 • Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Prevention
Last updated Jun 15, 2026 19:08 UTC
-
VR game fights germs: study tests fun way to keep kids healthy
Prevention ENROLLING_BY_INVITATIONThis study tests whether a virtual reality (VR) game can help primary schoolchildren (ages 6-12) learn and practice better hygiene to prevent the spread of COVID-19 and other respiratory viruses. About 2,160 children will either play the VR game for two weeks or receive standard …
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Prevention
Last updated Jun 15, 2026 18:55 UTC
-
New combo shot aims to boost flu protection
Prevention OngoingThis study tests whether giving a high-dose flu vaccine together with a new long-acting antiviral drug, CD388, is safe and does not weaken the body's immune response. About 100 healthy adults aged 18 to 49 will receive either the vaccine plus CD388 or the vaccine plus a placebo. …
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Prevention
Last updated Jun 11, 2026 12:11 UTC
-
New gum surgery technique aims for longer-lasting smile fix
Symptom relief OngoingThis study compares a new surgical method (gingivalstat) to the standard approach for correcting a gummy smile in 22 adults. The goal is to see which method keeps the gum line more stable over 6 months after surgery. Participants must have a specific type of gummy smile and be in…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Magnesium may boost sleep and brain power in healthy adults
Symptom relief OngoingThis study looked at whether taking 400 mg of magnesium citrate daily for 90 days could improve sleep quality and thinking skills in healthy Saudi adults who had poor sleep. 41 adults took part, with one group getting the supplement and another group getting nothing. Researchers …
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: Umm Al-Qura University • Aim: Symptom relief
Last updated Jun 08, 2026 13:05 UTC
-
Healthy men needed to compare two injection methods for a cancer drug
Knowledge-focused OngoingThis study checks if two different devices for injecting trastuzumab under the skin work the same way in the body. It involves 312 healthy men who will get a single dose. The goal is to see if the drug levels are similar, not to treat any disease.
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Jun 16, 2026 20:43 UTC
-
Healthy volunteers needed to test new mRNA drug safety
Knowledge-focused OngoingThis early-stage study tests whether the experimental drug mRNA-0184 is safe in healthy adults. About 52 participants will receive one or more doses and be monitored for side effects. The study does not aim to treat any disease, but to gather important safety and drug-level infor…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: Knowledge-focused
Last updated Jun 16, 2026 20:33 UTC
-
Brain zaps and sleep: can ultrasound tweak anesthesia?
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether focused ultrasound to the brain can change how the anesthetic propofol works. Ten healthy adults will receive both real and fake ultrasound while under sedation. Researchers will measure brain signals and response times to see if ultrasound alters anesthe…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE4 • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 16, 2026 20:33 UTC
-
Healthy volunteers help test copycat drug against approved biologic
Knowledge-focused OngoingThis study tests a new drug called QL2106 against an approved drug, Tremfye® (guselkumab), in 190 healthy adults aged 18-45. The goal is to compare how the body processes each drug, their safety, and immune response after a single dose. Participants receive one injection and are …
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC
-
Music over silence: lebanese study tests pain relief through song
Knowledge-focused OngoingThis study looks at whether listening to self-chosen Levantine music can change how much pressure pain a person can tolerate, compared to sitting in silence. Thirty-two healthy young adults in Lebanon will take part, each experiencing both silence and music in a random order. The…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: charbel najem • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC
-
Compression boots put to the test: can they speed up athlete recovery?
Knowledge-focused OngoingThis study looks at whether using intermittent pneumatic compression (IPC) boots after exercise helps college athletes recover faster. Researchers will measure blood lactate (a sign of muscle fatigue), ankle flexibility, and jump performance in 38 NCAA athletes. The goal is to se…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: University of Redlands • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
Healthy volunteers test drug interactions for future diabetes care
Knowledge-focused OngoingThis study looks at how a new drug called AZD5004 changes the way the body handles two diabetes medications, mitiglinide and pioglitazone. It involves 32 healthy adults and does not aim to treat any disease. The goal is to gather safety and drug-level information to guide future …
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
New drug AZD0292 tested in healthy japanese volunteers for first time
Knowledge-focused OngoingThis early-phase study tests the safety and tolerability of a new drug called AZD0292 in 18 healthy Japanese adults. Participants receive a single dose of the drug or a placebo by IV infusion. The goal is to see how the body processes the drug and check for any side effects.
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
Just 40 seconds of exercise a week? new study tests the 'Micro-Workout' promise
Knowledge-focused OngoingThis study looks at whether a very short, intense workout—just one or two 10-20 second bike sprints, twice a week—can improve heart and lung fitness in inactive adults. Sixty healthy, overweight but otherwise healthy participants will do this for 9 weeks. Researchers will measure…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: California State University, San Marcos • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Healthy volunteers help test new Drug's safety
Knowledge-focused OngoingThis early-stage study tests the safety and how the body handles a single dose of IBI3033 in 32 healthy Chinese adults. Participants receive either the drug or a placebo and are monitored for side effects and drug levels over 12 weeks. The goal is to gather safety data, not to tr…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Healthy adults needed to test new Drug's safety
Knowledge-focused OngoingThis early-stage study tests a new drug called INCA033989 in 72 healthy adults aged 18 to 55. Participants receive a single dose either as an injection under the skin or through an IV. The goal is to measure how the drug moves through the body and check for any side effects. This…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Vitamin D's hidden role in TB and fungal lung disease revealed
Knowledge-focused OngoingThis study looks at whether vitamin D levels are linked to certain immune markers in people with active tuberculosis (TB), with or without a chronic fungal lung infection called aspergillosis. Researchers will compare blood samples from 300 adults—including healthy volunteers—to …
Matched conditions: HEALTHY PARTICIPANTS
Sponsor: Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Breathing Warm-Up may boost athletic performance, study says
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a special breathing warm-up can improve the strength of muscles used for breathing in athletes during exercise. About 28 trained athletes aged 14-30 will try three different routines: a breathing warm-up, a fake warm-up, and no warm-up. The goal is to …
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: Hitit University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
Healthy volunteers help compare new biosimilar to taltz
Knowledge-focused OngoingThis study tests whether a new biosimilar medicine (CT-P52) works similarly to the approved drug Taltz in the body. It involves 218 healthy adults aged 19 to 55 who receive a single dose of either the biosimilar or Taltz. The main goal is to compare how the drug is absorbed and i…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:01 UTC
-
Healthy volunteers test new drug tablet forms
Knowledge-focused OngoingThis study looks at how well three different tablet versions of the drug LY4100511 are absorbed by the body in 48 healthy adults. It also checks if taking a common stomach acid medicine (a proton pump inhibitor) changes absorption. The goal is to find the best tablet form for fut…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Pillow CPR: a cheaper way to save lives?
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether using a simple pillow can teach CPR as effectively as a standard manikin. Researchers will compare compression depth, number of compressions, and hand position in 128 healthy adults. The goal is to find a more affordable and accessible training tool for n…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: University of Beykent • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
Healthy men help track how new drug moves through the body
Knowledge-focused OngoingThis study looks at how healthy men absorb, break down, and get rid of a test medicine called AZD4144. Eight men aged 30 to 65 will receive a single dose either by mouth or through a vein. A tiny radioactive tag lets researchers follow the drug's path in the body.
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
Scientists scan brains to see how massage really works
Knowledge-focused OngoingThis study looks at how a single session of Swedish massage or light touch therapy changes brain activity, heart rate, blood pressure, breathing, and mood in healthy adults. Thirty participants will be randomly assigned to receive either massage or light touch. Brain scans (MRI) …
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC
-
New drug STAR-0310 put to the test in healthy people
Knowledge-focused OngoingThis early-stage study tests a new drug called STAR-0310 in 40 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor for side effects. This study does not aim to treat any disease; it is a fir…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Astria Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC
-
Scientists watch brain and heart in stroke survivors
Knowledge-focused OngoingThis study looks at brain activity and heart patterns in people who have had a stroke and compares them to healthy adults. Researchers use special head sensors and heart monitors to measure differences. The goal is to better understand how stroke changes the brain and heart. No t…
Matched conditions: HEALTHY PARTICIPANTS
Sponsor: Pusan National University Yangsan Hospital • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:06 UTC
-
Paxlovid copycat tablets tested in healthy volunteers – study pulled
Knowledge-focused TerminatedThis study was designed to check if new combination tablets of nirmatrelvir and ritonavir work the same as the already-approved Paxlovid tablets. It was planned for about 28 healthy adults aged 18 and older, who would take single doses of different tablet forms under fasting cond…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:06 UTC
-
Talking heals: study tests if Psych-Coaching boosts cancer care skills
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether four one-hour coaching sessions with a psycho-oncologist can help doctors and nurses who treat cancer patients. The goal is to improve how they talk with patients and handle difficult emotions. 62 oncology physicians and nurses will take part, and rese…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:29 UTC
-
Healthy volunteers help test new combo pill
Knowledge-focused OngoingThis study tests whether a single tablet containing both laroprovstat and rosuvastatin works the same as taking each drug separately. It involves 44 healthy adults aged 18 to 55 who will receive single doses of different tablet forms. The goal is to compare how the body absorbs t…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC
-
Study aims to cut unnecessary eye doctor visits for contact lens wearers
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how often people who wear contact lenses need to visit their optician. Right now, there are no clear rules on the number of follow-up visits needed. The goal is to create better guidelines to make care both safe and efficient. About 300 healthy adults aged 18 …
Matched conditions: HEALTHY PARTICIPANTS
Sponsor: Aston University • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:28 UTC
-
Healthy volunteers help Fine-Tune blood thinner reversal drug
Knowledge-focused OngoingThis early-stage study tests how different doses of andexanet reverse the effects of common blood thinners (rivaroxaban or apixaban) and how it interacts with another blood thinner, enoxaparin. It involves 179 healthy adults and measures blood clotting activity. The goal is to ga…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC
-
Healthy volunteers needed to test safety of experimental drug AG-236
Knowledge-focused OngoingThis early-stage study tests whether a single injection of AG-236 is safe and tolerable in healthy adults aged 18 to 55. About 24 participants will receive either the drug or a placebo. The study does not aim to treat any disease, but to gather important safety and drug-level inf…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC
-
Can heat and foam rolling boost your jump?
Knowledge-focused OngoingThis study looks at how heat therapy and foam rolling change the force athletes can produce in their legs during a squat jump. Researchers will measure jump force and leg strength in 38 healthy college athletes. The goal is to understand if these simple treatments can improve mus…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: University of Redlands • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:06 UTC
-
Healthy volunteers help test new drug IBI3033 for safety
Knowledge-focused OngoingThis early-stage study tests the safety and how the body handles a new drug called IBI3033 in 8 healthy Chinese adults. Participants receive either the drug or a placebo and are monitored for side effects and drug levels over 20 weeks. The study does not aim to treat any disease,…
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:05 UTC
-
Safety training for nursing leaders: will it change minds?
Knowledge-focused OngoingThis study looks at whether an educational program on patient safety can shift the perceptions of nursing leaders and educators in a Saudi medical city. About 102 head nurses, assistant head nurses, supervisors, and educators will take a survey before the training, then again at …
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: Universiti Putra Malaysia • Aim: Knowledge-focused
Last updated Jun 02, 2026 11:59 UTC
-
New brain tests could sharpen Alzheimer's prevention research
Knowledge-focused TerminatedThis study aims to develop better tools for measuring thinking skills and daily function in healthy older adults. Researchers will compare new computerized tests with standard ones over one year. The goal is to find measures that are more accurate and less affected by practice, w…
Matched conditions: HEALTHY PARTICIPANTS
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 01, 2026 17:54 UTC